Emergency pharmaceutical - winrevair 45MG/vial
Ended Awarded
- Contract number
- 36C26126N0330
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,391
Award facts
- Contract value 100% obligated
- $21,390.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rahway, NJ 07065, USA
Award details come from SAM.gov/FPDS.
About this award
Merck Sharp & Dohme LLC was awarded a delivery order valued at $21,390.85 for emergency pharmaceutical procurement of WINREVAIR 45mg/vial under the Department of Veterans Affairs' Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The delivery order, issued on February 9, 2026, with performance completion by September 30, 2026, will be fulfilled at Merck's manufacturing facility in Rahway, New Jersey. This award represents a competitive procurement without set-aside designation, drawing from the $5.84 billion parent FSS-61-IB contract that the Department of Veterans Affairs awarded to Merck on June 1, 2025, with performance extending through May 31, 2030. WINREVAIR (sotatercept-csrk) is a specialty therapeutic used for pulmonary hypertension treatment and has been supplied by Merck to multiple Veterans Integrated Service Network entities under previous delivery orders.
As a major pharmaceutical manufacturer headquartered in Rahway, New Jersey, Merck serves as a critical supplier to the Department of Veterans Affairs and other federal healthcare agencies including the Centers for Disease Control and Prevention, Department of Health and Human Services, and Department of Defense. The company's substantial federal contracting portfolio encompasses vaccines, medical countermeasures, and specialty therapeutics, including notable programs such as molnupiravir COVID-19 antiviral development and ERVEBO Zaire ebolavirus vaccine procurement. The emergency nature of this WINREVAIR delivery order underscores the Department of Veterans Affairs' reliance on established vendor relationships through the FSS-61-IB vehicle to ensure rapid availability of critical medications for beneficiary care.
Quick answers
Who was awarded contract 36C26126N0330?
36C26126N0330 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on February 9, 2026.
How much is contract 36C26126N0330 worth?
The government has obligated $21,391 on 36C26126N0330.
Is contract 36C26126N0330 an order under another contract?
Yes. 36C26126N0330 is a delivery order under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0330 competed?
The extent of competition for 36C26126N0330 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award